Charles River Laboratories International, Inc. CRL

292.84 (1.60) (0.54%) as of 25 Sep
Market cap
$14.1B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Charles River Laboratories International, Inc. (CRL) Net margin

Charles River Laboratories International, Inc.'s net margin over the twelve months to 30 June 2026 was −5.96%, down 2.4 percentage points from fiscal 2025 (−3.59%). Over the past ten years it has ranged from −3.59% (fiscal 2025) to 12.5% (fiscal 2020) — the current reading is the lowest in ten years. That is above the Diagnostics & Research industry median of −6.37% and below the Healthcare sector median of 0.00%.

Net margin, annual

Annual

Period Net margin Change (points)
FY2025 −3.59% (3.84)
FY2024 0.25% (11.24)
FY2023 11.5% (0.74)
FY2022 12.2% 1.19
FY2021 11.0% (1.42)
FY2020 12.5% 2.85
FY2019 9.61% (0.38)
FY2018 9.99% 3.35
FY2017 6.64% (2.56)
FY2016 9.20% (1.75)

Quarterly

Period Net margin Change (points)
Jun 2026 −0.15% 1.34
Mar 2026 −1.49% 26.33
Dec 2025 −27.8% (33.24)
Sep 2025 5.42% 0.35
42 more quarters

Against its own ten years

Low −3.59% High 12.5%
Ten-year median 9.99%
Current reading's percentile 9

Net margin against peers

Company Net margin
QGEN QIAGEN N.V. compare 19.5%
MEDP Medpace Holdings, Inc. compare 17.7%
DGX Quest Diagnostics Incorporated compare 9.15%
RVTY Revvity Inc. compare 8.16%
LH Labcorp Holdings Inc. compare 6.99%
ICLR ICON PLC compare 0.51%
CRL Charles River Laboratories International, Inc. −5.96%
TWST Twist Bioscience Corporation compare −31.7%
GH Guardant Health, Inc. compare −38.3%
Diagnostics & Research industry median −6.37%
Healthcare sector median 0.00%
Market median 0.55%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on CRL